Who
Sean Martin
Chief Legal Officer & GC
Company insider
Files Form 4 as: Chief Legal Officer & GC, Generate Biomedicines; SVP and General Counsel, Baxter International; SVP, General Counsel, Apollo Education Group.
In numbers
- Trades disclosed
- 124
- Buys
- 1
- Sells
- 13
- Bought
- $804K
- Sold
- $8.1M
- Companies
- 3
- Companies where not an officer
- 0
- First trade
- 15 Oct 2010
- Last trade
- 26 Feb 2026
- Last filed
- 2 Mar 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 26 Feb 2026filed 2 Mar 2026 | GENB Generate Biomedicinesoption or derivative · Biotechnology | SEC FORM 4 Code A | —190,034 at $0.00 | filing |
| 26 Feb 2026filed 2 Mar 2026 | GENB Generate Biomedicinesoption or derivative · Biotechnology | SEC FORM 4 Code A | —190,034 at $0.00 | filing |
| 2 Mar 2022filed 4 Mar 2022 | BAX Baxter Internationaloption or derivative · Medical Devices | SEC FORM 4 Code A | —31,008 at $0.00 | filing |
| 2 Mar 2022filed 4 Mar 2022 | BAX Baxter InternationalMedical Devices | SEC FORM 4 Code A | —6,688 at $0.00 | filing |
| 10 Feb 2022filed 14 Feb 2022 | BAX Baxter InternationalMedical Devices | SEC FORM 4 Code A | —1,604 at $0.00 | filing |
| 10 Feb 2022filed 14 Feb 2022 | BAX Baxter InternationalMedical Devices | SEC FORM 4 Code A | —4,636 at $0.00 | filing |
| 10 Feb 2022filed 14 Feb 2022 | BAX Baxter InternationalMedical Devices | SEC FORM 4 Code F | $235K2,675 at $87.75 | filing |
| 1 Nov 2021filed 3 Nov 2021 | BAX Baxter Internationaloption or derivative · Medical Devices | SEC FORM 4 Code M | —21,450 at $0.00 | filing |
| 1 Nov 2021filed 3 Nov 2021 | BAX Baxter InternationalMedical Devices | SEC FORM 4 Code M | $1.1M21,450 at $50.77 | filing |
| 1 Nov 2021filed 3 Nov 2021 | BAX Baxter InternationalMedical Devices | SEC FORM 4 Sold | $1.6M19,876 at $79.53 | filing |
| 1 Nov 2021filed 3 Nov 2021 | BAX Baxter InternationalMedical Devices | SEC FORM 4 Sold | $126K1,574 at $80.03 | filing |
| 2 Aug 2021filed 4 Aug 2021 | BAX Baxter Internationaloption or derivative · Medical Devices | SEC FORM 4 Code M | —19,800 at $0.00 | filing |
| 2 Aug 2021filed 4 Aug 2021 | BAX Baxter InternationalMedical Devices | SEC FORM 4 Code M | $1.0M19,800 at $50.77 | filing |
| 2 Aug 2021filed 4 Aug 2021 | BAX Baxter InternationalMedical Devices | SEC FORM 4 Sold | $1.5M19,800 at $77.26 | filing |
| 3 Mar 2021filed 5 Mar 2021 | BAX Baxter Internationaloption or derivative · Medical Devices | SEC FORM 4 Code A | —63,360 at $0.00 | filing |
| 16 Feb 2021filed 18 Feb 2021 | BAX Baxter InternationalMedical Devices | SEC FORM 4 Code A | —881 at $0.00 | filing |
| 16 Feb 2021filed 18 Feb 2021 | BAX Baxter InternationalMedical Devices | SEC FORM 4 Code A | —3,225 at $0.00 | filing |
| 16 Feb 2021filed 18 Feb 2021 | BAX Baxter InternationalMedical Devices | SEC FORM 4 Code F | $199K2,552 at $77.80 | filing |
| 16 Feb 2021filed 18 Feb 2021 | BAX Baxter InternationalMedical Devices | SEC FORM 4 Code A | —726 at $0.00 | filing |
| 2 Nov 2020filed 4 Nov 2020 | BAX Baxter Internationaloption or derivative · Medical Devices | SEC FORM 4 Code M | —47,001 at $0.00 | filing |
News
What's next for Cambodia: G Adventures' Bruce Poon Tip and Sean Martin on its brighter futuretravelweekly.com.au · 9 Oct 2026Baxter International (NYSE:BAX) Stock Picked Up by Analysts at BarclaysBAX · tickerreport.com · 9 Oct 2026
1 headline in the last 90 days name Sean Martin; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.